Simultaneous overexpression of multidrug efflux pumps in Pseudomonas aeruginosa non-cystic fibrosis clinical isolates

The purpose of this study was to examine expression and regulation of 6 multidrug efflux systems, including MexAB-OprM, MexCD-OprJ, MexEF-OprN, MexXY, MexJK, and MexVW, in 13 non-cystic fibrosis (CF) clinical isolates of Pseudomonas aeruginosa. These isolates displayed a high level of resistance to many clinically important antibiotics. Some isolates simultaneously overexpressed up to 4 different Mex systems, as determined by quantitative real-time reverse transcription PCR. None of the isolates overexpressed MexCD-OprJ, and only 1 isolate overproduced MexJK. All the isolates overexpressed MexXY, while overexpression of MexEF-OprN and MexVW was common. DNA sequencing analysis of regulatory genes showed that no clear correlation could be established among (i) the presence of mutations, (ii) the type of mutations, (iii) the expression level of the Mex systems, and (iv) resistance to antibiotic substrates. The results suggest that the concomitant overexpression of some Mex systems may superimpose their antimicrobial drug efflux capabilities, contributing to the multidrug resistance phenotype in the P. aeruginosa non-CF clinical isolates. The existence of uncharacterized regulators for the Mex systems was signified.

Medienart:

E-Artikel

Erscheinungsjahr:

2014

Erschienen:

2014

Enthalten in:

Zur Gesamtaufnahme - volume:60

Enthalten in:

Canadian journal of microbiology - 60(2014), 7 vom: 07. Juli, Seite 437-43

Sprache:

Englisch

Beteiligte Personen:

Poonsuk, Kanchana [VerfasserIn]
Tribuddharat, Chanwit [VerfasserIn]
Chuanchuen, Rungtip [VerfasserIn]

Links:

Volltext

Themen:

Anti-Bacterial Agents
Bacterial Outer Membrane Proteins
Journal Article
Membrane Transport Proteins
Multidrug efflux system
Multidrug resistance
Multirésistance aux médicaments
Pseudomonas aeruginosa
RNA, Bacterial
Research Support, Non-U.S. Gov't
Système d’efflux polychimiothérapeutique

Anmerkungen:

Date Completed 28.09.2014

Date Revised 02.12.2018

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1139/cjm-2014-0239

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM238990524